Doctors question evidence behind Pentagon plan for testosterone screening

The U.S. defense secretary, Pete Hegseth, has ordered annual testosterone-deficiency screening for active-duty and reserve service members aged 30 and older. Hegseth stated the measure aims to bolster military readiness by addressing potential health issues.

However, this directive has drawn skepticism from numerous medical professionals. They question the scientific evidence supporting the plan's effectiveness in enhancing military readiness. Concerns have been raised that the screening and subsequent treatment could lead to unintended negative consequences for service members.

“

soldiers aged 30 and older in the US military will be screened for low testosterone

Critics warn that inappropriate prescription of testosterone could increase risks, including infertility and other adverse health effects. These medical experts advocate for a more cautious approach, emphasizing the need for robust evidence before implementing widespread screening and treatment protocols within the military.

“

it might do nothing of the sort and instead could increase service members’ risk of infertility or other consequences if testosterone is prescribed inappropriately.